SoniVie Presents Clinical Trial Data Supporting the Safety and Efficacy of the TIVUS™ System in the Treatment of Pulmonary Arterial Hypertension

TROPHY1 data presented in Late-Breaking Trial Session at EuroPCR 2019 SoniVie, an Israeli company developing a novel system for the treatment of pulmonary arterial hypertension (PAH), today announced the presentation of positive data from a multi-center international...
SEARCH FOR STUDIES